Showing results (141-150 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United StatesKarin Butler, Sarah-Jane Anderson, Olivia Hayward, et al.Journal of Managed Care & Specialty Pharmacy|June 24, 2021
Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United StatesChristopher F Bell, Cori Blauer-Peterson, Jianbin MaoJournal of Managed Care & Specialty Pharmacy|June 24, 2021
Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysisThomas E Hutson, Frank X Liu, Christopher Dieyi, et al.Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community PharmaciesPatricia Quintana-Bárcena, Anne Lord, Annie Lizotte, et al.Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or HypertensionMelissa Johnson, Rebecca Jastrzab, Jared Tate, et al.Journal of Managed Care & Specialty Pharmacy|February 1, 2018
An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary InterventionArinze Nkemdirim Okere, Kyrian Ezendu, Abdrahmane Berthe, et al.Journal of Managed Care & Specialty Pharmacy|December 18, 2018
Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims DatabaseSteven R Feldman, Haijun Tian, Xinyue Wang, et al.Journal of Managed Care & Specialty Pharmacy|June 10, 2022
Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye diseaseDenise M Visco, Laura H Hendrix, Lucille Sun, et al.Journal of Managed Care & Specialty Pharmacy|June 14, 2022
AMCP Partnership Forum: The evolving role of digital therapeuticsJournal of Managed Care & Specialty Pharmacy|July 1, 2022
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosusTyler O'Malley, Fenglong Xie, Yujie Su, et al.Pageof 185